ResultsIntegrated Filing- Financial
AHCL's board approved Q2 & H1 FY26 standalone results.
Amrutanjan Health Care LimitedAMRUTANJAN · Filed with the exchange
Revenue from operations for Q2 rose 7.1% YoY to ₹117.70 Cr.
Net profit surged 18.3% YoY to ₹13.96 Cr, with EPS at ₹4.83. For H1 FY26, revenue increased 9.4% to ₹211.75 Cr, and net profit jumped 35.7% to ₹22.27 Cr.
This strong profit growth was aided by total expenses growing slower than revenue, partly due to a slight dip in advertisement spending.
The board also announced a ₹1 per share interim dividend.
These results reflect strong financial momentum, driven by effective cost management and revenue growth.
No comments yet. Be the first.